Armistice Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-500,000
Closed -$8.02M 178
2022
Q1
$8.02M Sell
500,000
-636,000
-56% -$11.4M 0.16% 80
2021
Q4
$27.8M Sell
1,136,000
-188,000
-14% -$4.41M 0.45% 48
2021
Q3
$30.8M Buy
1,324,000
+588,000
+80% +$14.2M 0.52% 56
2021
Q2
$20.2M Buy
+736,000
New +$21M 0.36% 68

Other funds holding AHCO

Armistice Capital's AHCO Position: Q2 2022 in Review

Armistice Capital sold out of AdaptHealth (AHCO) in Q2 2022, closing a stake of 500,000 shares — an estimated $8.02M sold.

Armistice Capital first reported a position in AHCO in Q2 2021 and held it in 4 quarters. The position peaked at $30.8M in Q3 2021. 149 funds tracked by Wall St. Rank hold AHCO as of Q2 2022.

  • Armistice Capital reported no remaining AdaptHealth position as of Q2 2022 after selling out during the quarter.
  • Armistice Capital sold 500,000 AdaptHealth shares in Q2 2022, an estimated $8.02M.
  • Armistice Capital first reported a position in AdaptHealth in Q2 2021 and held it in 4 quarters.
  • Armistice Capital's AdaptHealth position peaked at $30.8M in Q3 2021.
  • 149 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2022.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.